NEWS & MEDIA

ALL

PRESS RELEASES

MEDIA

IN CONVERSATION

September 9, 2024

Join Us at the Annual Fall Meetings in Miami Beach

Aerin Medical will showcase our innovative solutions at the upcoming ENT fall conferences in Miami. Don’t miss the chance to connect, learn, and discover how we are expanding access to meaningful relief for patients suffering from chronic ENT conditions.

Read More

May 10, 2024

The VA Hospital Experience with Dr. Meha Fox and Dr. Alex Choi

At the Michael E. DeBakey Veterans Affairs Medical Center in Houston, VivAer® and RhinAer® are being utilized to enhance the otolaryngology residents’ training program.

Read More

February 29, 2024

New Two-Year Results Show Sustained Improvement in Chronic Rhinitis Symptoms Following a Single Procedure with Aerin Medical’s RhinAer®

Positive 24-month results from RHINTRAC, a randomized, sham-controlled clinical trial, in the International Forum of Allergy & Rhinology (IFAR). These results demonstrate the durable treatment effect of RhinAer® for treating chronic rhinitis, showing a significant improvement in symptoms through two years. These findings build on the previously published results of two separate studies that also demonstrated significant, sustained improvement with RhinAer treatment.

Read More

February 8, 2024

Aerin Medical Announces Positive Two-year Outcomes from the VATRAC Trial of VivAer®

Positive two-year outcomes from the VATRAC trial has been published in the Rhinology Journal. The study showed a single in-office treatment with VivAer® resulted in sustained improvement in symptoms of nasal airway obstruction (NAO) caused by nasal valve collapse, and reduced both daytime sleepiness and the use of medications and mechanical aids.

Read More

December 5, 2023

Aerin Medical Announces Sustained Clinical and Quality-of-Life Improvements Two Years After Chronic Rhinitis Treatment with RhinAer®

Two-year results of the RELIEF clinical trial published in The Laryngoscope confirm that a single procedure with RhinAer® resulted in sustained improvements in chronic rhinitis symptoms and quality of life, along with a substantial decrease in chronic rhinitis medication usage. RhinAer, a non-invasive technology developed by Aerin Medical Inc., uses temperature-controlled radiofrequency energy to provide relief from chronic rhinitis.

Read More

November 20, 2023

Derrick Sung Joins Aerin Medical as Chief Financial Officer

Derrick Sung has been appointed chief financial officer of Aerin Medical. Sung brings over 25 years of finance, capital market, and strategy experience across diverse roles within the medical device industry. Prior to joining Aerin Medical, Sung was CFO at Pulmonx Corporation where he scaled the finance organization and led the company through significant growth and a successful IPO.

Read More

November 3, 2023

Aerin Medical Announces Advances for Chronic Rhinitis Treatment with New CPT® Code and Final CMS-Established Payment Rates

Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, announced today that the Centers for Medicare and Medicaid Services (CMS) assigned payment for a new Category I Current Procedural Terminology (CPT®) code for endoscopic destruction of the posterior nasal nerve (PNN) using radiofrequency ablation.

Read More

October 18, 2023

VivAer® and RhinAer® Featured on BabyBoomers.com

VivAer® and RhinAer® were featured on BabyBoomers.com, an online resource for those embracing their golden years. In the article, Dr. Roheen Raithatha, FACS, FARS, discussed the changes in nasal anatomy and function that accompany aging, highlighting solutions available to address resulting chronic nasal conditions.

Read More

August 29, 2023

Aerin Medical Co-Founders Discuss 100,000 Patient Milestone

Aerin Medical co-founders, Scott Wolf, MD, and Andrew Frazier, reflect on the milestone achievement of 100,000 patients treated and share what’s next for the company. 

Read More

July 13, 2023

Aerin Medical Announces New Positive Two‑Year Results from VivAer® AERWAY Study

 Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, today announced the publication of positive two-year follow-up data from the AERWAY trial for patients with severe or extreme nasal airway obstruction (NAO) due to nasal valve collapse (NVC)

Read More

April 18, 2023

Aerin Medical Supports AAO-HNS Position Recognizing Nasal Valve Repair as a Distinct Procedure that Improves Nasal Obstruction Symptoms

Aerin Medical supports the recent American Academy of Otolaryngology-Head and Neck Surgery position statement. The statement recognizes nasal valve repair as “a distinct surgical procedure that can improve nasal obstruction symptoms for appropriately selected patients.”

Read More

January 23, 2023

VivAer® Patient and ENT Physician Share Their Story with Key News Publications

VivAer® was recently featured in key news publications such as the San Francisco Chronicle, the Houston Chronicle, the Miami Herald, and more, following a patient testimonial campaign that reached millions of Americans.

Read More

January 2, 2023

VivAer® Featured in Woman’s World Magazine

VivAer® was featured in Woman’s World Magazine, a popular print publication reaching over one million Americans. The full-page article highlighted the story of Diana, a VivAer patient whose inability to breathe through her nose left her exhausted throughout the day.

Read More

November 16, 2022

Aerin Medical Announces CMS Set to Implement New CPT® Code for Temperature-Controlled Radiofrequency Repair of Nasal Valve Collapse

CMS is set to implement a new CPT code that includes the use of VivAer to repair nasal valve collapse in the office and outpatient surgical settings. The new code goes into effect on January 1, 2023. VivAer is a non-invasive, temperature-controlled radiofrequency technology that provides long-term relief from nasal obstruction.

Read More

October 18, 2022

Aerin Medical Announces Establishment of a New CPT® Code for Endoscopic Destruction of the Posterior Nasal Nerve Using Radiofrequency Ablation

The American Medical Association (AMA) Current Procedural Terminology (CPT®) Editorial Panel accepted the application for a new Category I CPT code to report endoscopic destruction of the posterior nasal nerve using radiofrequency (RF) ablation…

Read More

Oct 11, 2022

Dr. Randall A. Ow, Q&A Experience with RhinAer

We spoke with Dr. Randall A. Ow regarding his experience with RhinAer…

Read More

October 11, 2022

VivAer® Featured in BackTable ENT Podcast

VivAer® was featured in a BackTable ENT podcast discussing in-office procedures for nasal valve obstruction. The podcast, featuring Dr. Mary Ashmead of Texas Ear, Nose, & Throat Specialists, was developed as a resource for otolaryngologists to learn tips, techniques, and practical advice on patient selection, treatment planning, and more.

Read More

September 8, 2022

Aerin Medical Receives FDA Clearance of Next-Generation RhinAer® Stylus for Treatment of Patients with Chronic Rhinitis

Stylus now launching in the U.S. at American Rhinologic Society (ARS) and American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNSF) annual meetings…

Read More

September 6, 2022

New 12-month Results from the VATRAC Trial Confirm Durable Efficacy of Aerin Medical’s VivAer® in Patients with Nasal Valve Collapse

Twelve-month active treatment group outcomes from the VATRAC trial published in JAMA Otolaryngology – Head & Neck Surgery confirm that treatment with VivAer® resulted in a reduction in nasal obstruction symptoms with durable improvement through 12 months. VivAer uses temperature-controlled radiofrequency energy to provide long-term relief from nasal obstruction.

Read More

Aug 12, 2022

RhinAer® RHINTRAC Randomized Controlled Trial Results Featured in Clinical News Outlet

RhinAer®, the comprehensive, non-invasive solution for chronic rhinitis, was recently featured in specialty clinical news outlet, Healio. The article highlighted the results of the RHINTRAC randomized controlled trial published in International Forum of Allergy & Rhinology,…

Read More

Jul 20, 2022

RhinAer® Two-Year Trial Results Featured in Clinical News Outlet

RhinAer®, the comprehensive, office-friendly solution for chronic rhinitis, was recently featured in specialty clinical news outlet, Healio…

Read More

Jul 19, 2022

Dr. V. Vasu Kakarlapudi, Q&A Published 2-year Pivotal RhinAer Study

We spoke with Dr. V. Vasu Kakarlapudi, primary investigator of the published 2-year pivotal RhinAer study. …

Read More

July 19, 2022

New Study of Aerin Medical’s RhinAer® Shows Positive Clinical and Quality-of-Life Results Following Treatment for Chronic Rhinitis

Largest study of RhinAer to date shows 87% of patients reported quality-of-life improvements…

Read More

July 15, 2022

VivAer® Featured in Dental Sleep Practice Magazine

VivAer® was featured in Dental Sleep Practice Magazine. The article, titled “Nasal Airway Obstruction and Precision Oral Appliance Therapy in the Treatment of OSA”, discussed the connection between nasal airway obstruction (NAO) and sleep disordered breathing as well as the importance of treating NAO before oral appliance therapy is used in the treatment of obstructive sleep apnea (OSA).

Read More

July 6, 2022

New 12-month Results from RHINTRAC Randomized Controlled Trial Demonstrate Durable Safety and Efficacy of Aerin Medical’s RhinAer® for Treatment of Chronic Rhinitis

Follow-up results from the trial’s active treatment arm showed that chronic rhinitis symptoms continued to improve …

Read More

June 29, 2022

Four-Year Results Show Aerin Medical’s VivAer® Treatment Provides Significant, Sustained Relief of Nasal Obstruction Symptoms

Long term follow-up published in International Forum of Allergy & Rhinology demonstrates…

Read More

June 16, 2022

Aerin Medical Secures $60 Million in Equity Financing

Ally Bridge Group joins existing syndicate of KCK MedTech, Questa Capital and OrbiMed…

Read More

June 7, 2022

Aerin Medical’s RhinAer® Demonstrates Long-term Safety and Efficacy for Treatment of Chronic Rhinitis in Newly Published Two-year Study

RhinAer treatment resulted in significant symptom improvement through 24 months in both non-allergic and allergic rhinitis patients…

Read More

Jun 06, 2022

ABC-Affiliate Interviews RhinAer® Physician and Patient

RhinAer was featured on ABC-affiliate SoFlo Health TV as the “innovative new procedure you won’t want to miss.” In the interview, Dr. Jay Young, M.D., explained…

Read More

Feb 01, 2022

Aerin Medical Founder, Scott Wolf, MD, Profiled by The Tech Tribune

Aerin Medical founder, Scott Wolf, MD was featured in an exclusive founder interview series by The Tech Tribune…

Read More

Jan 18, 2022

Sleep Review Highlights VivAer® and RhinAer® as Advances Shifting Nasal Airway Procedures from Operating Room to In‑Office

More and more nasal airway procedures are moving from the operating room to an office setting. “Some of the main drivers of this change have been patient convenience, recovery time, and cost”, says Dr. Stanley McClurg, MD, FARS of ENT Associates in Kansas City, MO…

Read More

Jan 06, 2022

Aerin Medical Receives 2022 Best Tech Startup Award

We are honored to announce that Aerin Medical was named one of the best tech startups in Sunnyvale by The Tech Tribune …

Read More

Dec 15, 2021

9News Denver (NBC-affiliate) Interviews VivAer® Physician and Patient

Dr. Raj P. TerKonda, M.D., FACS, explains nasal airway obstruction and who may be a good candidate for treatment with VivAer …

Read More

Oct 07, 2021

VivAer® Clinical Research Recognized at American Rhinologic Society Annual Meeting

Congratulations to Stacey Silvers, MD, Jon Rosenthal, DO, Chad McDuffie, MD, David Yen, MD, and Joseph Han, MD. This team was recognized by the American Rhinologic Society …

Read More

September 27, 2021

Aerin Medical Announces Key Events at American Rhinologic Society and American Academy of Otolaryngology 2021 Meetings

Results of Two Clinical Trials Evaluating Safety, Efficacy of VivAer® for Nasal Obstruction Patients with Nasal Valve Collapse to be Presented …

Read More

September 13, 2021

Results Published from RHINTRAC Randomized Controlled Trial Demonstrate Safety and Efficacy of Aerin Medical’s RhinAer® For Treatment of Chronic Rhinitis

Treatment with RhinAer resulted in significant symptom burden reduction, superior to sham control …

Read More

Aug 16, 2021

Aerin Medical Announces Positive One-Year Results from RhinAer® Pivotal Trial for the Treatment of Chronic Rhinitis

RhinAer provided significant and lasting improvement in common chronic rhinitis symptoms, such as postnasal drip, congestion, nasal itching and persistent runny nose …

Read More

Aug 05, 2021

Positive Aerin Medical AERWAY Study Results Published Showing Effectiveness of VivAer® For Nasal Obstruction Patients with Nasal Valve Collapse

Study adds to a growing body of clinical evidence supporting the safety and efficacy of VivAer, a non-invasive, temperature-controlled radiofrequency device …

Read More

Jul 13, 2021

Aerin Medical Announces Results of Randomized Controlled Trial Supporting VivAer® for Treatment of Nasal Airway Obstruction with Nasal Valve Collapse

Treatment with VivAer, a non-invasive, temperature-controlled, radiofrequency (RF) device, resulted in significant symptom relief, superior to sham control …

Read More

May 11, 2021

Matt Brokaw, One-Year Reflection

Matt Brokaw recently marked his one-year anniversary as CEO of Aerin Medical. To recognize the milestone, Matt sat down to answer some questions and share his reflections on the past year. …

Read More

May 06, 2021

RhinAer® Receives 2021 MedTech Breakthrough Award for Best New Therapeutic Solution

We are honored to announce that MedTech Breakthrough has named Aerin Medical the winner in the 2021 MedTech Breakthrough Awards program, taking home the “Best New Therapeutic Solution” award for RhinAer, our innovative treatment for chronic rhinitis. …

Read More

Apr 21, 2021

Two-Year Results Demonstrating Long-Term Effectiveness of Aerin Medical’s VivAer® Treatment of Nasal Obstruction Published in International Forum of Allergy & Rhinology

Data shows in-office treatment of nasal valve collapse resulted in lasting improvement in symptoms and quality of life …

Read More

Aug 17, 2020

Aerin Medical Announces Appointment of Matt Brokaw as President and CEO and Closing of $48MM Equity Financing

Aerin Medical, a privately held medical device company focused on non-invasive procedures for treating nasal airway conditions, today announced the closing of a $48 million equity financing. …

Read More

Aug 17, 2020

Aerosol Generation with Common Rhinologic Devices: Cadaveric Study Conducted in a Surgical Suite

Aerosol-generating medical procedures present potential risk to practitioners, particularly during the SARS CoV-2 (COVID-19) pandemic. Particles <100 µm in diameter can be infectious ...

Read More

Aug 17, 2020

Quality-of-life impact after in-office treatment of nasal valve obstruction with a radiofrequency device

Chronic nasal obstruction contributes to a decreased quality of life. Nasal valve dysfunction is increasingly recognized as a cause of nasal obstruction …

Read More

Mar 06, 2020

Aerin Medical Announces FDA Clearance and U.S. Launch of Innovative Nonsurgical Procedure for Chronic Rhinitis

RhinAer™ Procedure Promises Lasting Relief for Millions of Americans Suffering from Common Chronic Condition …

Read More

May 06, 2019

New Non-Invasive Technique Promises Hope For Troubled Breathing

Judging by all the ads for things from nasal strips to sprays to medications, there are a lot of people who have trouble breathing …

Read More

Feb 13, 2019

Non-Invasive Nasal Procedure Helps Patients Breathe Easier in Minutes

Tim Carr, a firefighter in Culver City, had tried lots of remedies for his blocked nasal airways. “I’ve gone through allergy treatments. I’ve gone through sinus sprays. I’ve gone through all kinds of different things,” he said …

Read More

Feb 04, 2019

In‐office Treatment of Nasal Valve Obstruction Using a Novel, Bipolar Radiofrequency Device

A Vivaer® Nasal Airway Remodeling pivotal study was recently published in Laryngoscope Investigative Otolaryngology. The prospective, multi-center, non-randomized US Pivotal Study was conducted to evaluate the treatment of nasal airway obstruction using the Vivaer® System …

Read More

Feb 01, 2019

New Solution to Breathing Problems Available in Alabama

A new procedure to fix patients’ breathing problems is being offered in Alabama. Around 20 million Americans have trouble breathing through their nose. Quick and easy fixes have been hard to find, until the Food and Drug Administration approved technology in 2017 that allows patients to breathe normally again without surgery. This comes as a relief for patients like Mike Lahurd, who said breathing has been an issue since 1992 …

Read More

Jan 03, 2019

Non-randomized Evaluation of a Novel Low Energy Radiofrequency Treatment for Nasal Obstruction and Snoring

A Vivaer® Nasal Airway Remodeling study on nasal obstruction and snoring was published in the European Archives of Oto-Rhino-Laryngology. The article covered a prospective, non-randomized study using Vivaer® to treat nasal obstruction and snoring …

Read More

Oct 08, 2018

WCNC Welcomes Dr. Daron Smith from Cornerstone ENT

Dr. Daron Smith of Cornerstone ENT visits the Charlotte Today show on WCNC to discuss the Vivaer® Nasal Airway Remodeling procedure …

Read More

Aug 24, 2018

Tony Vanetti of WHAS Goes Under the Vivaer® Stylus

Tony Vanetti, a host at WHAS, has the Vivaer® Nasal Airway Remodeling procedure performed by Dr. Vasu Kakarlapudi of Advanced ENT and Allergy. Aerin Medical may provide links to third-party sites …

Read More

Jul 31, 2018

Aerin Medical Achieves Milestone with over 1,000 Patients Treated with VIVAER

Aerin Medical, Inc. (“Aerin”) announced that over 1,000 patients suffering from nasal obstruction have successfully received the Vivaer® Nasal Airway Remodeling treatment (“Vivaer®“) which uses patented non-invasive low temperature radio frequency technology to reshape nasal tissues …

Read More

May 23, 2018

New Treatment for Nasal Airway Obstruction

“From start to finish, the procedure wasn’t even half an hour, and that includes the numbing and the procedure,” Linda Wells said. “Once the healing was done, I was amazed at how much better I could breathe.” …

Read More

Jan 09, 2018

Aerin Launching a Novel Non-invasive Solution for Nasal Airway Obstruction

Aerin Medical, Inc. (“Aerin”) announced that it has received regulatory clearance for its novel Vivaer® Non-Invasive Airway Remodeling System (“Vivaer®“), a product developed to enable Ear, Nose & Throat (“ENT”) physicians to treat nasal airway obstruction within their physician office without the need for incisions or implants …

Read More

February 29, 2024

New Two-Year Results Show Sustained Improvement in Chronic Rhinitis Symptoms Following a Single Procedure with Aerin Medical’s RhinAer®

Positive 24-month results from RHINTRAC, a randomized, sham-controlled clinical trial, in the International Forum of Allergy & Rhinology (IFAR). These results demonstrate the durable treatment effect of RhinAer® for treating chronic rhinitis, showing a significant improvement in symptoms through two years. These findings build on the previously published results of two separate studies that also demonstrated significant, sustained improvement with RhinAer treatment.

Read More

February 8, 2024

Aerin Medical Announces Positive Two-year Outcomes from the VATRAC Trial of VivAer®

Positive two-year outcomes from the VATRAC trial has been published in the Rhinology Journal. The study showed a single in-office treatment with VivAer® resulted in sustained improvement in symptoms of nasal airway obstruction (NAO) caused by nasal valve collapse, and reduced both daytime sleepiness and the use of medications and mechanical aids.

Read More

December 5, 2023

Aerin Medical Announces Sustained Clinical and Quality-of-Life Improvements Two Years After Chronic Rhinitis Treatment with RhinAer®

Two-year results of the RELIEF clinical trial published in The Laryngoscope confirm that a single procedure with RhinAer® resulted in sustained improvements in chronic rhinitis symptoms and quality of life, along with a substantial decrease in chronic rhinitis medication usage. RhinAer, a non-invasive technology developed by Aerin Medical Inc., uses temperature-controlled radiofrequency energy to provide relief from chronic rhinitis.

Read More

November 20, 2023

Derrick Sung Joins Aerin Medical as Chief Financial Officer

Derrick Sung has been appointed chief financial officer of Aerin Medical. Sung brings over 25 years of finance, capital market, and strategy experience across diverse roles within the medical device industry. Prior to joining Aerin Medical, Sung was CFO at Pulmonx Corporation where he scaled the finance organization and led the company through significant growth and a successful IPO.

Read More

November 3, 2023

Aerin Medical Announces Advances for Chronic Rhinitis Treatment with New CPT® Code and Final CMS-Established Payment Rates

Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, announced today that the Centers for Medicare and Medicaid Services (CMS) assigned payment for a new Category I Current Procedural Terminology (CPT®) code for endoscopic destruction of the posterior nasal nerve (PNN) using radiofrequency ablation.

Read More

July 13, 2023

Aerin Medical Announces New Positive Two‑Year Results from VivAer® AERWAY Study

 Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, today announced the publication of positive two-year follow-up data from the AERWAY trial for patients with severe or extreme nasal airway obstruction (NAO) due to nasal valve collapse (NVC)

Read More

April 18, 2023

Aerin Medical Supports AAO-HNS Position Recognizing Nasal Valve Repair as a Distinct Procedure that Improves Nasal Obstruction Symptoms

Aerin Medical supports the recent American Academy of Otolaryngology-Head and Neck Surgery position statement. The statement recognizes nasal valve repair as “a distinct surgical procedure that can improve nasal obstruction symptoms for appropriately selected patients.”

Read More

November 16, 2022

Aerin Medical Announces CMS Set to Implement New CPT® Code for Temperature-Controlled Radiofrequency Repair of Nasal Valve Collapse

CMS is set to implement a new CPT code that includes the use of VivAer to repair nasal valve collapse in the office and outpatient surgical settings. The new code goes into effect on January 1, 2023. VivAer is a non-invasive, temperature-controlled radiofrequency technology that provides long-term relief from nasal obstruction.

Read More

October 18, 2022

Aerin Medical Announces Establishment of a New CPT® Code for Endoscopic Destruction of the Posterior Nasal Nerve Using Radiofrequency Ablation

The American Medical Association (AMA) Current Procedural Terminology (CPT®) Editorial Panel accepted the application for a new Category I CPT code to report endoscopic destruction of the posterior nasal nerve using radiofrequency (RF) ablation…

Read More

September 8, 2022

Aerin Medical Receives FDA Clearance of Next-Generation RhinAer® Stylus for Treatment of Patients with Chronic Rhinitis

Stylus now launching in the U.S. at American Rhinologic Society (ARS) and American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNSF) annual meetings…

Read More

September 6, 2022

New 12-month Results from the VATRAC Trial Confirm Durable Efficacy of Aerin Medical’s VivAer® in Patients with Nasal Valve Collapse

Twelve-month active treatment group outcomes from the VATRAC trial published in JAMA Otolaryngology – Head & Neck Surgery confirm that treatment with VivAer® resulted in a reduction in nasal obstruction symptoms with durable improvement through 12 months. VivAer uses temperature-controlled radiofrequency energy to provide long-term relief from nasal obstruction.

Read More

July 19, 2022

New Study of Aerin Medical’s RhinAer® Shows Positive Clinical and Quality-of-Life Results Following Treatment for Chronic Rhinitis

Largest study of RhinAer to date shows 87% of patients reported quality-of-life improvements…

Read More

July 6, 2022

New 12-month Results from RHINTRAC Randomized Controlled Trial Demonstrate Durable Safety and Efficacy of Aerin Medical’s RhinAer® for Treatment of Chronic Rhinitis

Follow-up results from the trial’s active treatment arm showed that chronic rhinitis symptoms continued to improve …

Read More

June 29, 2022

Four-Year Results Show Aerin Medical’s VivAer® Treatment Provides Significant, Sustained Relief of Nasal Obstruction Symptoms

Long term follow-up published in International Forum of Allergy & Rhinology demonstrates…

Read More

June 16, 2022

Aerin Medical Secures $60 Million in Equity Financing

Ally Bridge Group joins existing syndicate of KCK MedTech, Questa Capital and OrbiMed…

Read More

June 7, 2022

Aerin Medical’s RhinAer® Demonstrates Long-term Safety and Efficacy for Treatment of Chronic Rhinitis in Newly Published Two-year Study

RhinAer treatment resulted in significant symptom improvement through 24 months in both non-allergic and allergic rhinitis patients…

Read More

September 27, 2021

Aerin Medical Announces Key Events at American Rhinologic Society and American Academy of Otolaryngology 2021 Meetings

Results of Two Clinical Trials Evaluating Safety, Efficacy of VivAer® for Nasal Obstruction Patients with Nasal Valve Collapse to be Presented …

Read More

September 13, 2021

Results Published from RHINTRAC Randomized Controlled Trial Demonstrate Safety and Efficacy of Aerin Medical’s RhinAer® For Treatment of Chronic Rhinitis

Treatment with RhinAer resulted in significant symptom burden reduction, superior to sham control …

Read More

Aug 16, 2021

Aerin Medical Announces Positive One-Year Results from RhinAer® Pivotal Trial for the Treatment of Chronic Rhinitis

RhinAer provided significant and lasting improvement in common chronic rhinitis symptoms, such as postnasal drip, congestion, nasal itching and persistent runny nose …

Read More

Aug 05, 2021

Positive Aerin Medical AERWAY Study Results Published Showing Effectiveness of VivAer® For Nasal Obstruction Patients with Nasal Valve Collapse

Study adds to a growing body of clinical evidence supporting the safety and efficacy of VivAer, a non-invasive, temperature-controlled radiofrequency device …

Read More

Jul 13, 2021

Aerin Medical Announces Results of Randomized Controlled Trial Supporting VivAer® for Treatment of Nasal Airway Obstruction with Nasal Valve Collapse

Treatment with VivAer, a non-invasive, temperature-controlled, radiofrequency (RF) device, resulted in significant symptom relief, superior to sham control …

Read More

Apr 21, 2021

Two-Year Results Demonstrating Long-Term Effectiveness of Aerin Medical’s VivAer® Treatment of Nasal Obstruction Published in International Forum of Allergy & Rhinology

Data shows in-office treatment of nasal valve collapse resulted in lasting improvement in symptoms and quality of life …

Read More

Aug 17, 2020

Aerin Medical Announces Appointment of Matt Brokaw as President and CEO and Closing of $48MM Equity Financing

Aerin Medical, a privately held medical device company focused on non-invasive procedures for treating nasal airway conditions, today announced the closing of a $48 million equity financing. …

Read More

Mar 06, 2020

Aerin Medical Announces FDA Clearance and U.S. Launch of Innovative Nonsurgical Procedure for Chronic Rhinitis

RhinAer™ Procedure Promises Lasting Relief for Millions of Americans Suffering from Common Chronic Condition …

Read More

Feb 04, 2019

In‐office Treatment of Nasal Valve Obstruction Using a Novel, Bipolar Radiofrequency Device

A Vivaer® Nasal Airway Remodeling pivotal study was recently published in Laryngoscope Investigative Otolaryngology. The prospective, multi-center, non-randomized US Pivotal Study was conducted to evaluate the treatment of nasal airway obstruction using the Vivaer® System …

Read More

Jan 03, 2019

Non-randomized Evaluation of a Novel Low Energy Radiofrequency Treatment for Nasal Obstruction and Snoring

A Vivaer® Nasal Airway Remodeling study on nasal obstruction and snoring was published in the European Archives of Oto-Rhino-Laryngology. The article covered a prospective, non-randomized study using Vivaer® to treat nasal obstruction and snoring …

Read More

Jul 31, 2018

Aerin Medical Achieves Milestone with over 1,000 Patients Treated with VIVAER

Aerin Medical, Inc. (“Aerin”) announced that over 1,000 patients suffering from nasal obstruction have successfully received the Vivaer® Nasal Airway Remodeling treatment (“Vivaer®“) which uses patented non-invasive low temperature radio frequency technology to reshape nasal tissues …

Read More

Jan 09, 2018

Aerin Launching a Novel Non-invasive Solution for Nasal Airway Obstruction

Aerin Medical, Inc. (“Aerin”) announced that it has received regulatory clearance for its novel Vivaer® Non-Invasive Airway Remodeling System (“Vivaer®“), a product developed to enable Ear, Nose & Throat (“ENT”) physicians to treat nasal airway obstruction within their physician office without the need for incisions or implants …

Read More

October 18, 2023

VivAer® and RhinAer® Featured on BabyBoomers.com

VivAer® and RhinAer® were featured on BabyBoomers.com, an online resource for those embracing their golden years. In the article, Dr. Roheen Raithatha, FACS, FARS, discussed the changes in nasal anatomy and function that accompany aging, highlighting solutions available to address resulting chronic nasal conditions.

Read More

January 23, 2023

VivAer® Patient and ENT Physician Share Their Story with Key News Publications

VivAer® was recently featured in key news publications such as the San Francisco Chronicle, the Houston Chronicle, the Miami Herald, and more, following a patient testimonial campaign that reached millions of Americans.

Read More

January 2, 2023

VivAer® Featured in Woman’s World Magazine

VivAer® was featured in Woman’s World Magazine, a popular print publication reaching over one million Americans. The full-page article highlighted the story of Diana, a VivAer patient whose inability to breathe through her nose left her exhausted throughout the day.

Read More

October 11, 2022

VivAer® Featured in BackTable ENT Podcast

VivAer® was featured in a BackTable ENT podcast discussing in-office procedures for nasal valve obstruction. The podcast, featuring Dr. Mary Ashmead of Texas Ear, Nose, & Throat Specialists, was developed as a resource for otolaryngologists to learn tips, techniques, and practical advice on patient selection, treatment planning, and more.

Read More

Aug 12, 2022

RhinAer® RHINTRAC Randomized Controlled Trial Results Featured in Clinical News Outlet

RhinAer®, the comprehensive, non-invasive solution for chronic rhinitis, was recently featured in specialty clinical news outlet, Healio. The article highlighted the results of the RHINTRAC randomized controlled trial published in International Forum of Allergy & Rhinology,…

Read More

Jul 20, 2022

RhinAer® Two-Year Trial Results Featured in Clinical News Outlet

RhinAer®, the comprehensive, office-friendly solution for chronic rhinitis, was recently featured in specialty clinical news outlet, Healio…

Read More

July 15, 2022

VivAer® Featured in Dental Sleep Practice Magazine

VivAer® was featured in Dental Sleep Practice Magazine. The article, titled “Nasal Airway Obstruction and Precision Oral Appliance Therapy in the Treatment of OSA”, discussed the connection between nasal airway obstruction (NAO) and sleep disordered breathing as well as the importance of treating NAO before oral appliance therapy is used in the treatment of obstructive sleep apnea (OSA).

Read More

Jun 06, 2022

ABC-Affiliate Interviews RhinAer® Physician and Patient

RhinAer was featured on ABC-affiliate SoFlo Health TV as the “innovative new procedure you won’t want to miss.” In the interview, Dr. Jay Young, M.D., explained…

Read More

Feb 01, 2022

Aerin Medical Founder, Scott Wolf, MD, Profiled by The Tech Tribune

Aerin Medical founder, Scott Wolf, MD was featured in an exclusive founder interview series by The Tech Tribune…

Read More

Jan 18, 2022

Sleep Review Highlights VivAer® and RhinAer® as Advances Shifting Nasal Airway Procedures from Operating Room to In‑Office

More and more nasal airway procedures are moving from the operating room to an office setting. “Some of the main drivers of this change have been patient convenience, recovery time, and cost”, says Dr. Stanley McClurg, MD, FARS of ENT Associates in Kansas City, MO…

Read More

Jan 06, 2022

Aerin Medical Receives 2022 Best Tech Startup Award

We are honored to announce that Aerin Medical was named one of the best tech startups in Sunnyvale by The Tech Tribune …

Read More

Dec 15, 2021

9News Denver (NBC-affiliate) Interviews VivAer® Physician and Patient

Dr. Raj P. TerKonda, M.D., FACS, explains nasal airway obstruction and who may be a good candidate for treatment with VivAer …

Read More

Oct 07, 2021

VivAer® Clinical Research Recognized at American Rhinologic Society Annual Meeting

Congratulations to Stacey Silvers, MD, Jon Rosenthal, DO, Chad McDuffie, MD, David Yen, MD, and Joseph Han, MD. This team was recognized by the American Rhinologic Society …

Read More

May 06, 2021

RhinAer® Receives 2021 MedTech Breakthrough Award for Best New Therapeutic Solution

We are honored to announce that MedTech Breakthrough has named Aerin Medical the winner in the 2021 MedTech Breakthrough Awards program, taking home the “Best New Therapeutic Solution” award for RhinAer, our innovative treatment for chronic rhinitis. …

Read More

Aug 17, 2020

Aerosol Generation with Common Rhinologic Devices: Cadaveric Study Conducted in a Surgical Suite

Aerosol-generating medical procedures present potential risk to practitioners, particularly during the SARS CoV-2 (COVID-19) pandemic. Particles <100 µm in diameter can be infectious ...

Read More

Aug 17, 2020

Quality-of-life impact after in-office treatment of nasal valve obstruction with a radiofrequency device

Chronic nasal obstruction contributes to a decreased quality of life. Nasal valve dysfunction is increasingly recognized as a cause of nasal obstruction …

Read More

May 06, 2019

New Non-Invasive Technique Promises Hope For Troubled Breathing

Judging by all the ads for things from nasal strips to sprays to medications, there are a lot of people who have trouble breathing …

Read More

Feb 13, 2019

Non-Invasive Nasal Procedure Helps Patients Breathe Easier in Minutes

Tim Carr, a firefighter in Culver City, had tried lots of remedies for his blocked nasal airways. “I’ve gone through allergy treatments. I’ve gone through sinus sprays. I’ve gone through all kinds of different things,” he said …

Read More

Feb 01, 2019

New Solution to Breathing Problems Available in Alabama

A new procedure to fix patients’ breathing problems is being offered in Alabama. Around 20 million Americans have trouble breathing through their nose. Quick and easy fixes have been hard to find, until the Food and Drug Administration approved technology in 2017 that allows patients to breathe normally again without surgery. This comes as a relief for patients like Mike Lahurd, who said breathing has been an issue since 1992 …

Read More

Oct 08, 2018

WCNC Welcomes Dr. Daron Smith from Cornerstone ENT

Dr. Daron Smith of Cornerstone ENT visits the Charlotte Today show on WCNC to discuss the Vivaer® Nasal Airway Remodeling procedure …

Read More

Aug 24, 2018

Tony Vanetti of WHAS Goes Under the Vivaer® Stylus

Tony Vanetti, a host at WHAS, has the Vivaer® Nasal Airway Remodeling procedure performed by Dr. Vasu Kakarlapudi of Advanced ENT and Allergy. Aerin Medical may provide links to third-party sites …

Read More

May 23, 2018

New Treatment for Nasal Airway Obstruction

“From start to finish, the procedure wasn’t even half an hour, and that includes the numbing and the procedure,” Linda Wells said. “Once the healing was done, I was amazed at how much better I could breathe.” …

Read More

September 9, 2024

Join Us at the Annual Fall Meetings in Miami Beach

Aerin Medical will showcase our innovative solutions at the upcoming ENT fall conferences in Miami. Don’t miss the chance to connect, learn, and discover how we are expanding access to meaningful relief for patients suffering from chronic ENT conditions.

Read More

May 10, 2024

The VA Hospital Experience with Dr. Meha Fox and Dr. Alex Choi

At the Michael E. DeBakey Veterans Affairs Medical Center in Houston, VivAer® and RhinAer® are being utilized to enhance the otolaryngology residents’ training program.

Read More

August 29, 2023

Aerin Medical Co-Founders Discuss 100,000 Patient Milestone

Aerin Medical co-founders, Scott Wolf, MD, and Andrew Frazier, reflect on the milestone achievement of 100,000 patients treated and share what’s next for the company. 

Read More

Oct 11, 2022

Dr. Randall A. Ow, Q&A Experience with RhinAer

We spoke with Dr. Randall A. Ow regarding his experience with RhinAer…

Read More

Jul 19, 2022

Dr. V. Vasu Kakarlapudi, Q&A Published 2-year Pivotal RhinAer Study

We spoke with Dr. V. Vasu Kakarlapudi, primary investigator of the published 2-year pivotal RhinAer study. …

Read More

May 11, 2021

Matt Brokaw, One-Year Reflection

Matt Brokaw recently marked his one-year anniversary as CEO of Aerin Medical. To recognize the milestone, Matt sat down to answer some questions and share his reflections on the past year. …

Read More
WEB1321-05.B